GuangZhou Cellgenes Biotechnology Co., Ltd.

Works in Cardiovascular · GI & liver · Neurology · Respiratory

GuangZhou Cellgenes Biotechnology Co., Ltd. is a clinical trial sponsor. It has 2 active clinical trials with 117 planned participants, in Cardiovascular, GI & liver, Neurology and Respiratory. Since 2021 it has completed 2 trials and stopped 0 early.

Trial track record · since 2021

2Active trials117 planned participants
2Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 2 active trials

StageTrialStatus

Questions about GuangZhou Cellgenes Biotechnology Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-28.

Approve Suite is not affiliated with GuangZhou Cellgenes Biotechnology Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.